ROCHESTER, N.Y., Oct. 5, 2022 /PRNewswire-PRWeb/ -- InfinityRx recently launched its proprietary PSP platform in addressing some of the most important dynamics impacting copay assistance programs and exceeding expectations for market access for its clients. Co-founded by two veteran New York pharmacists, the company boasts a cloud-based platform that offers a unique and easy-to-administer digital method for brand pharmaceutical drug manufacturers to buy-down expensive prescription medication. The InfinityRx platform delivers a flexible, mobile, and innovative rules engine that electronically drives a targeted price discount or copay assistance to high-cost medications at the POS retail level and all sites of care for treatment. A manufacturer can customize its target price and program benefits directly into the InfinityRx signature proprietary platform and make changes that become effective and fully operational for patients to experience the benefit in real-time, under 24-hours versus historical platforms that can take up to thirty days to deploy. The company's platform is a necessary tool that enables prescription drug manufacturers the ability to help patients avoid prescription drug abandonment, and to reduce medication non-adherence which for years has been reported as a nationwide pandemic.
- a Rochester, New York, Healthcare Advisory and Market Development Firm announced today that it has inked a deal to represent InfinityRx, a cutting-edge New York based company that developed a progressive, efficient, and cost-effective patient affordability platform for Patient Service Programs (PSP).
- Third, the product and service model are engineered to support a niche market while proving innovative and inventive to its buyer."
- InfinityRx service programs help patients achieve their therapeutic goals while cultivating growth and profitability for their clients.
- InfinityRx is passionate about inspiring pharmaceutical companies, healthcare service providers, and all others who share their commitment to join them in reshaping the future of healthcare.